chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Similar to my first vaccine dose but less severe.  I was able to report to tele-work but it was hard.  I woke up in the middle of the night after receiving the vaccine and had trouble going back to sleep.  I was having trouble regulating my body temperature, I was swinging from hot to cold all day.  I felt weak all day.  I had lower appetite.  Symptoms should get better in 36 hours.  In the end I am glad to have the vaccine and be safe, thank you for all you do.
Client stated that he received his MPX1 at Health Center on 08/19/2022. He stated that he  was given his MPX1 on his left forearm. The first day it became itchy and swollen and sore, a bright red  color. Today 09/02/2022 he stated that it's a dark reddish purple color, were they administered the  vaccine on his forearm. He said it's the size of an eraser and it's getting darker, the client stated again  a dark reddish purple color and he stated he has a cold now too. He wanted to know if this was part of  the side effects from the vaccine. The client was advised that his information was being escalated to  leadership. Patient stares that the area is no longer sore or itching. Patient denies pain, area being warm to touch. He is mainly concerned with the discoloration of the area. Patient also states that he has been ill for the last couple of weeks since returning from a cruise. Advised to contact PCP if increase in symptoms occurs. Patient will contact his physician next week.
Site: Bruising at Injection Site-Mild, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Medium, Additional Details: vaccine adminstered to right arm deltoid, slightly left of center of deltoid. patient reported today that he had a similar reaction last year on 01/29/2022 with pneumovax 23 which resolved with a few days.
Information has been received from a healthcare worker referring to a patient of unknown age and gender. Information about patient's concomitant medications, concurrent conditions and medical history was not reported. On an unspecified date the patient was vaccinated with a dose of improperly stored (temperature: 58 F and time frame: 2 hours) ROTATEQ (dose not reported, lot # L020865 with expiration date 09-FEB-2017) orally. It was reported that there was no previous temperature excursion. No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous prospective pregnancy report was received from a registered nurse and refers to a 14 year old female patient. No medical history and no concurrent conditions were reported. On 04-MAY-2016, the patient was exposed during pregnancy to VARIVAX, GARDASIL, VAQTA injection and MENACTRA (lot number, expiration date, dosage and route of administration were not provided for all vaccines). No concomitant therapies were reported. At the time of vaccine administration, the physician did not known that the patient was pregnant and was not aware of it until the patient's mother called the office after vaccines were given. The patient's pregnancy information was reported as "5 months pregnant", therefore the last menstrual period (LMP) was estimated as approximately January 2016, however, gestation has not been confirmed by a physician yet. Additionally, delivery date has been estimated as October 2016, therefore the pregnancy outcome was pending. No adverse event was reported. Additional information has been requested.
leg pain; swelling knee to mid back; upset stomach; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 71-years-old female patient (not pregnant) received first dose of bnt162b2 (BNT162B2, Batch/Lot number: unknown) administered in leg right, administration date 27Feb2021 (at 12:15) (age at the time of vaccination was 71-years-old) as DOSE 1, SINGLE for covid-19 immunization. Relevant medical history included: "Enlarged pulmonary artery" (unspecified if ongoing), notes: other medical history; "uranium poisoning" (unspecified if ongoing), notes: other medical history; "nephritis" (unspecified if ongoing), notes: other medical history; "Known allergies: Egg, Chicken" (unspecified if ongoing); "Known allergies: Rice" (unspecified if ongoing). Concomitant medication(s) included: BENADRYL; ACETAMINOPHEN; MELOXICAM. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 27Feb2021 16:30, outcome "recovered" (2021), described as "leg pain"; JOINT SWELLING (non-serious) with onset 27Feb2021 16:30, outcome "recovered" (2021), described as "swelling knee to mid back"; ABDOMINAL DISCOMFORT (non-serious) with onset 27Feb2021 16:30, outcome "recovered" (2021), described as "upset stomach". Therapeutic measures were taken as a result of pain in extremity, joint swelling, abdominal discomfort.  Additional Information: At 11:45 100mg Benadryl, 12:30 COVID shot, 50 mg BENADRYL every 4 hours for next 72 hours, leg pain and swelling knee to mid back, upset stomach, started METHYL PREDNISOLONE at 3:00 am itching on entire body. At 72 hours, all symptoms are gone feeling great. The patient did not have COVID prior to vaccination and since the vaccination was not tested for COVID.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected
pt complains of tiredness, sore arm, headache, nausea and vomiting x approx 24 hours starting a few hours after injection.   Patient was not well enough to work 8/14/21
Patient received flublok and comirnaty together in left arm.  Patient states it was really painful ,"like a cortisone shot/" when first shot, which was flu, was administered.  She thinks it was administered too high in the arm.  She had a really sore arm for 3 days and hasn't been able to lift her arm past her shoulder for 4 weeks now.
PFIZER COVID-19 VACCINE EUA: After receiving the Pfizer COVID-19 and Afluria vaccines on 101321, the patient called on 101421 complaining of arm soreness to the extent of "feeling like my arm is broken" on the side in which the Pfizer vaccine was administered. She also complained of persistent hiccups that began after receiving the vaccines. The patient was known to be pregnant at the time of vaccine administration, however, the estimated date of delivery is unknown.
This case was reported by a physician via call center representative and described the occurrence of shingles in a female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown. It was unknown if the reporter considered the shingles to be related to SHINGRIX. Additional information was received as follows: The age at vaccination was not reported. As per reporter the patient received SHINGRIX and was subsequently diagnosed with shingles.
R65.10 - SIRS (systemic inflammatory response syndrome) (CMS/HCC)
On 12/07/2021 vaccines were picked up from the state department to be stored in the fridge and used by 01/07/2022. This patient received the vaccine 10 days after the vaccine use by date. This patient reported no known symptoms.
pt recv vax, 7 days later devel inject site react by a 10-cm area of induration, warmth, rash & swelling. pt was seen by md
BEXSERO vaccine given on 7/26/16. Child c/o extreme fatigue and started with fever that evening. C/o hot/cold spells, feeling clammy, severe headache, body aches, and joint pain. Woke next day with facial swelling, severe sore throat, nausea, diarrhea and change in behavior. She kept asking what did she need to do next.
pt was into seizure on 4/7 @ 5:45am; pt breathing differently, rushed to hosp, 2hr later seizure under control
First told pharmacy of pain in her Right shoulder on 11/9/14. She did not say when the pain initially started, but that she was in pain on 11/8/14. She said she had decreased range of motion. She asked her physician about it at a previously scheduled appointment. Her physician said to keep using her arm, it would feel better. She continued to complain of pain and decreased range of motion in her left arm. She went to see her doctor again due to level of pain and continued limited range of motion on 11/18/14. At this time, her physician referred her to an orthopedic doctor and told her to avoid using her arm and prescribed pain relievers. She saw the orthopedic doctor on 11/20/14. She received a shot in her arm from that doctor and was told to rest her arm and referred for outpatient physicial therapy.
Patient developed chest pains and shortness of breath that has persisted for a couple of months and is gradually resolving.  She had presented to the ER after a couple of weeks and had negative cardiac troponins and normal EKG but had notable low platelet counts.  Subsequent follow-up primary care with persistent symptoms her D-dimer was negative  in platelets had returned normal but patient continued to have symptoms.  Symptoms have gradually improved.
Red swollen; fever;  and hard caked area. Stated Tuesday 11/4/2008, went to Clinic for treatment. Was given PREDNISONE and CLARITIN. Also advised to use the ice packs 20 min 4 times a day. Measured hard caked area at 6 cm by 5 cm.
She did not report further adverse event details; This was outside of the recommended administration schedule.; his initial dose of MMRlI and VARIVAX on l 1JUL2019 at the age of 2 years and 5 months old; This spontaneous report was received from a nurse referring to a male patient of 3 years old. Information regarding the patient's pertinent medical history, concurrent condition, drug reactions/allergies and concomitant medication was not provided. Concomitant therapies included varicella virus vaccine live (oka/merck) (VARIVAX).    On 11-JUL-2019, the patient was vaccinated with initial dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (albumin status of rHA (recombinant human albumin), lot # R029516, expiration date was reported as 14-OCT-2020, 0.5 ml, strength was not provided) and varicella virus vaccine live (oka/merck)(VARIVAX) for prophylaxis at the age of 2 years and 5 months old. He received his second dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (albumin status of rHA (recombinant human albumin), lot # S007813, expiration date was reported as 14-MAR-2021, 0.5 ml, strength was not provided) on 10-FEB-2020 (inappropriate schedule of product administration and product administered to patient of inappropriate age). This was outside of the recommended administration schedule. No further adverse event details.
two patients complain of nose bleeds after receiving the Pfizer vaccine; This is a spontaneous report received from a contactable Pharmacist via Pfizer sales representative. This Pharmacist reported similar events for two patients. This is 2nd of two reports. A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), via an unspecified route of administration on an unspecified date as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. It was stated that two patients complain of nose bleeds after receiving the pfizer vaccine on an unspecified date. Outcome of the event was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021786333 same reporter/drug/event, different patient
moderate anaphylaxis  - body shaking, rapid heart beat, high and fluctuating blood pressure, immediate dry throat and feeling of dehydration, stomach cramps followed by diarrhea about half hour after onset. Symptoms eased after 30-40 minutes so that I could get home and then diarrhea and weakness and shakiness for 3-4 hours. No epi pen administered because breathing was ok
Pt represents to clinic with a 4cm x 4cm round, red, area to left upper arm, that is warm to touch. No pain to area when touched. Informed pt to apply cool  compress to area and take some ibuprofen. And to return to clinic is symptoms persist or worsen.
Shingles within two weeks of receiving the first dose of the vaccine. No previous hx of shingles.  8 months pregnant at the time of the vaccine. Date of delivery: (Privacy). Babies birth weight: 7 pounds 14 ounces. No known health issues for baby at this time.
gen maculopapular eruption w/fever p/10 days of vax; rx APAP for fever
Information has been received from a health professional (Nurse) concerning an 18 year old female patient who in approximately April 2007, was vaccinated with a first dose 0.5 mL of Gardasil. The patient experienced pain in the injection site right after receiving the injection. Unspecified medical attention was sought. Subsequently, the patient recovered. Additional information is not expected.
he was having a procedure done; Tested positive for COVID19; This spontaneous case was reported by a consumer and describes the occurrence of SURGERY (he was having a procedure done) and SARS-COV-2 TEST POSITIVE (Tested positive for COVID19) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     The patient's past medical history included Atrial fibrillation (Atrial fibrillation for 20 years and treated by cardiologist.).    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for COVID19). On an unknown date, the patient experienced SURGERY (he was having a procedure done). The patient was treated with REMDESIVIR (iv drip) from 13-Apr-2021 to 17-Apr-2021 at a dose of 1 dosage form. At the time of the report, SURGERY (he was having a procedure done) and SARS-COV-2 TEST POSITIVE (Tested positive for COVID19) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 09-Apr-2021: Follow up attached - NNI On 26-May-2021: Follow up information received. treatment information were updated, past history details were updated.
After 30hrs severe migraine; chest rash; vomiting; diarrhea; low-heart rate; dizziness; blurry vision; This is a spontaneous report from a contactable consumer or other non-healthcare professional. A 41-years-old female patient (non-pregnant) received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection), via an unspecified route of administration, administered in Arm Left on 11May2021 17:15 (Batch/Lot number and Expiry date was not reported) (at the age of 41-years-old) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported.  The patient previously took tramadol and experienced allergy. The patient did not receive any other vaccine within 4 weeks of covid vaccine. The patient did not receive any medication within 2 weeks of covid vaccine. The patient did not have covid prior vaccination and was not tested for covid post vaccination. On 12May2021 18:00, the patient experienced after 30hrs severe migraine, chest rash, vomiting, diarrhea, dizziness and blurry vision. Laboratory tests on 12May2021 included heart rate: low. The events resulted in Doctor or other healthcare professional office/clinic visit. It was unknown if any treatment was received for the events. The clinical outcome of the events was not recovered.  No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.
First dose of vaccine was received on 12/22/2020. Became COVID test  positive on 12/30/2020. Had bodyaches, sore throat on 12/29/2020. Symptoms improved in 4 days.
Narrative: Resulted in ER visit. Second Pfizer dose given 45 days prior. Patient felt was related. Unsure with timing. Patient also obese and has hx of peroneal DVT
severe thyroid; This spontaneous case was reported by a patient family member or friend and describes the occurrence of THYROID DISORDER (severe thyroid) in a female patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced THYROID DISORDER (severe thyroid). At the time of the report, THYROID DISORDER (severe thyroid) outcome was unknown.            No concomitant medication information was provided.  It was reported that after receiving the fifth inoculation, the patient had sever thyroid for which the patient was under treatment.   This case was linked to US-MODERNATX, INC.-MOD-2023-696717 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-696717:Husband case
School called, 2 hours, post vax, and said pt was "blotchy and red and feeling warm and short of breath". Instructed to go to hospital. Seen in urgent care and dx'd with non-specific skin rash from possible allergic reaction; hives to chest and facial flushness. Treated with Benadryl, Prednisone and Pepcid oral medications.
pt appetite dec, lethargic & had a fever to 101.6R; pt adm to hosp for sepsis workup x 3 days;
Mom noticed bump on right thigh after vaccines given, mom denies any redness, no fever, still moving extremities.
This spontaneous report was received from licensed practical nurse regarding multiple unspecified patients of unknown age and gender. The patients' concurrent conditions, medical history and concomitant medications were not reported. On multiple unknown dates, multiple unspecified patients were administered improperly stored doses of PROQUAD, (lot number reported as N001489, expiration date 12-JUN-2018) or ZOSTAVAX (lot # M032141, expiration date 27-OCT-2017 and lot # M035692, expiration date 07-NOV-2017) (dose and site of administration for both vaccines were not reported) subcutaneously for prophylaxis. Concomitant medications included sterile diluent (lot number and expiration are unknown) which was properly stored. No adverse effects were reported. The vaccine doses were stored at 15 degrees Fahrenheit to 46 degrees Fahrenheit for a time frame of 2 hours 20 minutes for ZOSTAVAX and 40 minutes for PROQUAD. There was no previous temperature excursion reported. The call was made because of a data logger. No additional information is available. Additional information has been requested.
The patient made an appointment for the new Covid-19 Moderna (grey label) booster.  The contracted immunizer requested a new vial of bivalent moderna booster as she was running low.  The technician grabbed a vial from the refrigerator and verified with the pharmacist on duty.  The vial that was incorrectly grabbed was the monovalent Moderna booster (purple label).  The immunizer administered the monovalent booster to the patient.  When writing the lot number on the Vaccine Administration Record (VAR,) she realized the mistake.  She informed the patient.  She then administered a dose of the bivalent Moderna booster.  When this came to the pharmacist's attention, he called the Moderna medical phone line.  They referred him to the CDC medical phone line.  The pharmacist called the CDC and the representative  said that if a monovalent vaccine had been administered by mistake, the patient should wait two months before receiving a bivalent booster.  The pharmacist informed the immunizer of this guideline.  The pharmacist spoke with the patient on the phone.  She was aware of the mistake and reported no adverse reaction.
5 minutes after patient received vaccine patient reported he felt like he may have a seizure. He then had full body convulsions for about 5 seconds and then fainted. He was assisted to the floor by a staff member. He remained unconscious for approximately 15 seconds per the nurse monitoring the clinic. Patient received a dose of epi and albuterol inhaler. He felt nauseated after, but quickly improved. EMS was called to transport, patient declined and was taken to ER by private care, significant other to drive.
Cough, nausea, abdominal pain, muscle ache - on site and generalized.
itchy warm arm; itchy warm arm; her arm was red sore and slightly swollen; her arm was red sore and slightly swollen; her arm was red sore and slightly swollen; This is a spontaneous report from contactable nurse via a Pfizer sales representative. A female patient of an unspecified age received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (PREVNAR 13), via an unspecified route of administration on 13May2019 at a single dose in the right deltoid for immunization. The patient's medical history and concomitant medications were not reported. The patient previously took Pneumovax 23 on 10Nov2010 for immunization and experienced redness and swelling. It was reported that the patient was given pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) in the right deltoid on 13May2019 and complained of an itchy warm arm, her arm was red sore and slightly swollen on an unspecified date. She returned to the doctor today on 15May2019. Some of the symptoms are still there but dissipating. Outcome of the events was unknown.  Information on the lot/batch number has been requested.
This infant had a rash all over. Reported by the mother. Not seen by health care provider.
Systemic: Flushed / Sweating-Medium, Systemic: Nausea-Medium, Systemic: Vomiting-Medium, Systemic: Weakness-Medium
high blood pressure; Rapid heart rate; light headed; chills; fever; light headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HYPERTENSION (high blood pressure), DIZZINESS (light headed), CHILLS (chills), PYREXIA (fever) and HEADACHE (light headache) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included VITAMIN D NOS and CIMICIFUGA RACEMOSA EXTRACT (REMIFEMIN) for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced HYPERTENSION (high blood pressure), DIZZINESS (light headed), CHILLS (chills), PYREXIA (fever) and HEADACHE (light headache). 24-Feb-2021, the patient experienced HEART RATE INCREASED (Rapid heart rate). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency; METOPROLOL at a dose of 25 milligram once a day and LISINOPRIL at a dose of 10 milligram once a day. At the time of the report, HYPERTENSION (high blood pressure), DIZZINESS (light headed), CHILLS (chills), PYREXIA (fever), HEADACHE (light headache) and HEART RATE INCREASED (Rapid heart rate) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Feb-2021, Heart rate: 118 (abnormal) Evening after her nap her heart rate went up high to 118.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications was reported as Eye drops, Treatment details included Acetaminophen, Metoprolol 25mg/day, Lisinopril 10mg/day and for high blood pressure she was given medicine through IV.
Right upper arm from shoulder to just below deltoid swollen, red, and with warmth. Father stated this began 07/15/03 PM. Father has been applying ice packs. Will plan to see MD if not resolved by 07/18/03.